ID   AlAb
AC   CVCL_U957
SY   ALAB; Alab; A1Ab
DR   ATCC; CRL-7715
DR   cancercelllines; CVCL_U957
DR   CLS; 300280
DR   Cosmic; 1218871
DR   GEO; GSM783944
DR   Progenetix; CVCL_U957
DR   Wikidata; Q54749148
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RX   PubMed=77569;
RX   PubMed=212193;
RX   PubMed=327080;
RX   PubMed=833871;
RX   PubMed=3518877;
RX   PubMed=4329447;
RX   PubMed=6582512;
RX   PubMed=6935474;
RX   PubMed=7459858;
RX   PubMed=14490970;
CC   Problematic cell line: Possibly misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (STR profile).
CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC   HLA typing: A*02,09; B*w15; C*w02,w06 (PubMed=77569).
CC   Discontinued: ATCC; CRL-7715; true.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): CLS
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 12,13
ST   D16S539: 12
ST   D18S51: 15,17
ST   D21S11: 27,30.2
ST   D3S1358: 17
ST   D5S818: 12
ST   D7S820: 8,10
ST   D8S1179: 10,13
ST   FGA: 21,25
ST   Penta D: 9,12
ST   Penta E: 11,12
ST   TH01: 6,9.3
ST   TPOX: 8
ST   vWA: 17
DI   NCIt; C5214; Breast adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   54Y
CA   Cancer cell line
DT   Created: 16-04-14; Last updated: 05-10-23; Version: 17
//
RX   DOI=10.1016/B978-0-12-333530-2.50009-5;
RA   Leibovitz A.;
RT   "Cell lines from human breast.";
RL   (In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.161-184; Academic Press; New York (1994).
//
RX   PubMed=77569; DOI=10.1111/j.1399-0039.1978.tb01259.x;
RA   Espmark J.A., Ahlqvist-Roth L., Sarne L., Persson A.;
RT   "Tissue typing of cells in culture. III. HLA antigens of established
RT   human cell lines. Attempts at typing by the mixed hemadsorption
RT   technique.";
RL   Tissue Antigens 11:279-286(1978).
//
RX   PubMed=212193;
RA   Engel L.W., Young N.A.;
RT   "Human breast carcinoma cells in continuous culture: a review.";
RL   Cancer Res. 38:4327-4339(1978).
//
RX   PubMed=327080; DOI=10.1093/jnci/59.1.221;
RA   Fogh J., Fogh J.M., Orfeo T.;
RT   "One hundred and twenty-seven cultured human tumor cell lines
RT   producing tumors in nude mice.";
RL   J. Natl. Cancer Inst. 59:221-226(1977).
//
RX   PubMed=833871; DOI=10.1093/jnci/58.2.209;
RA   Fogh J., Wright W.C., Loveless J.D.;
RT   "Absence of HeLa cell contamination in 169 cell lines derived from
RT   human tumors.";
RL   J. Natl. Cancer Inst. 58:209-214(1977).
//
RX   PubMed=3518877; DOI=10.3109/07357908609038260;
RA   Fogh J.;
RT   "Human tumor lines for cancer research.";
RL   Cancer Invest. 4:157-184(1986).
//
RX   PubMed=4329447; DOI=10.1084/jem.133.3.454;
RA   Giraldo G., Beth-Giraldo E., Hirshaut Y., Aoki T., Old L.J., Boyse E.A.,
RA   Chopra H.C.;
RT   "Human sarcomas in culture. Foci of altered cells and a common
RT   antigen; induction of foci and antigen in human fibroblast cultures by
RT   filtrates.";
RL   J. Exp. Med. 133:454-478(1971).
//
RX   PubMed=6582512; DOI=10.1073/pnas.81.2.568;
RA   Mattes M.J., Cordon-Cardo C., Lewis J.L. Jr., Old L.J., Lloyd K.O.;
RT   "Cell surface antigens of human ovarian and endometrial carcinoma
RT   defined by mouse monoclonal antibodies.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:568-572(1984).
//
RX   PubMed=6935474; DOI=10.1093/jnci/66.2.239;
RA   Wright W.C., Daniels W.P., Fogh J.;
RT   "Distinction of seventy-one cultured human tumor cell lines by
RT   polymorphic enzyme analysis.";
RL   J. Natl. Cancer Inst. 66:239-247(1981).
//
RX   PubMed=7459858;
RA   Rousset M., Zweibaum A., Fogh J.;
RT   "Presence of glycogen and growth-related variations in 58 cultured
RT   human tumor cell lines of various tissue origins.";
RL   Cancer Res. 41:1165-1170(1981).
//
RX   PubMed=14490970;
RA   Reed M.V., Gey G.O.;
RT   "Cultivation of normal and malignant human lung tissue. I. The
RT   establishment of three adenocarcinoma cell strains.";
RL   Lab. Invest. 11:638-652(1962).
//